Implementing Basal-Prandial Insulin Therapy for Type 2 Diabetes
Author Information
Author(s): Steven Edelman, George Dailey, Thomas Flood, Louis Kuritzky, Susan Renda
Primary Institution: University of California San Diego, Veterans Affairs Medical Center, San Diego, CA, USA
Hypothesis
Can a practical approach to basal-prandial insulin therapy improve glycemic control in patients with type 2 diabetes?
Conclusion
Basal-prandial insulin therapy can effectively help patients with type 2 diabetes achieve better glycemic control.
Supporting Evidence
- Basal-prandial insulin therapy can be initiated in a simple stepwise manner.
- Patients with type 2 diabetes often fail to achieve glycemic control with oral medications alone.
- New insulin formulations can simplify the management of diabetes.
Takeaway
This study shows that using a specific insulin therapy can help people with diabetes manage their blood sugar better, making it easier for doctors to help their patients.
Methodology
The study involved a panel of clinical experts who developed recommendations for initiating basal-prandial insulin therapy in type 2 diabetes patients.
Potential Biases
Potential bias from the expert panel's affiliations with insulin manufacturers.
Limitations
The study may not address all patient demographics or the long-term effects of the therapy.
Participant Demographics
Patients with type 2 diabetes, including those newly diagnosed and those unable to achieve control with other therapies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website